Regulatory pathways for CGT and ATMP products


CGT is one of the world's fastest-growing therapeutic areas today. Instead of treating patients for the rest of their lives, these therapies offer them hope of a cure. As a result of expedited pathways, CGT product development timelines have been compressed, which presents developers with unique challenges and opportunities. As the CGT industry matures, guidance and regulatory standards continue to tighten and evolve, so developers must work closely with regulatory authorities.

In this infographic, we will review three tips for achieving regulatory success.